Inivata Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Inivata Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10367
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotide variants, insertions and deletions and structural variants in selected genes from DNA isolated from plasma samples from patients with non-small cell lung cancer; and InVisionSeq test. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctDNA analysis. The company has offices in the UK and the US. Inivata is headquartered in Cambridge, the UK.

Inivata Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inivata Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inivata Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inivata Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inivata Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Inivata Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inivata Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Inivata Raises USD45 Million in Series A Financing 10
Inivata Raises USD6.5 Million in Venture Financing 12
Partnerships 13
Genomics England, Inivata and Thermo Fisher Enter into Agreement 13
Addario Lung Cancer Enters into Agreement with Inivata 14
Biodesix Enters into Co-Development Agreement with Inivata 15
Inivata Ltd – Key Competitors 16
Inivata Ltd – Key Employees 17
Inivata Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Sep 12, 2018: Inivata announces senior management change 19
May 08, 2018: Michael Stocum to step down as Inivata CEO 20
Oct 26, 2017: Inivata Announces World-Leading SAB 21
Sep 08, 2017: Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer 22
Product News 23
Oct 17, 2017: Inivata Highlights New Clinical Data on InVision ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017 23
Jun 01, 2017: Inivata Highlights New Clinical Data on the InVision ctDNA Liquid Biopsy Platform in advanced NSCLC at ASCO 2017 Annual Meeting 24
Other Significant Developments 25
Mar 15, 2018: Inivata Announces Collaboration with MedStar Health to Utilize Liquid Biopsy to Advance Precision Cancer Genomics 25
Nov 01, 2017: Inivata Announces Strategic Partnership with West Cancer Center 26
Oct 13, 2017: Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes 27
Sep 07, 2017: Inivata: Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Inivata Ltd, Medical Equipment, Key Facts, 2017 2
Inivata Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Inivata Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inivata Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inivata Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inivata Ltd, Deals By Market, 2012 to YTD 2018 8
Inivata Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inivata Raises USD45 Million in Series A Financing 10
Inivata Raises USD6.5 Million in Venture Financing 12
Genomics England, Inivata and Thermo Fisher Enter into Agreement 13
Addario Lung Cancer Enters into Agreement with Inivata 14
Biodesix Enters into Co-Development Agreement with Inivata 15
Inivata Ltd, Key Competitors 16
Inivata Ltd, Key Employees 17
Inivata Ltd, Subsidiaries 18

List of Figures
Inivata Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Inivata Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Inivata Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Inivata Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Inivata Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inivata Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Inivata Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inivata Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Inivata Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AXA Egypt:企業の戦略・SWOT・財務情報
    AXA Egypt - Strategy, SWOT and Corporate Finance Report Summary AXA Egypt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Lumberg Connect GmbH:企業の戦略的SWOT分析
    Lumberg Connect GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nordex SE (NDX1):企業の財務・戦略的SWOT分析
    Nordex SE (NDX1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Teva Pharmaceutical Industries Ltd (TEVA)-医療機器分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Telefonica, S.A.:戦略・SWOT・企業財務分析
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Infineon Technologies AG (IFX):企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Great Bear Resources Ltd (GBR):企業の財務・戦略的SWOT分析
    Summary Great Bear Resources Ltd (GBRL) formerly Great Bear Uranium Corp, is a metals and mining company that offers minerals exploration and development services. The company acquires, mines, extracts, manages, explores, operates, produces, and develops uranium, gold, silver, base metals, and miner …
  • Ulthera Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ulthera Inc (Ulthera), a subsidiary of Merz Pharma GmbH & Co KgaA is a medical device company that develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technologies. The company’s therapeutic ultrasound platform technolo …
  • Jumboking Foods Pvt. Ltd.
    Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cushman & Wakefield Inc:企業のM&A・事業提携・投資動向
    Cushman & Wakefield Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cushman & Wakefield Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Steward Health Care System LLC:企業の戦略的SWOT分析
    Steward Health Care System LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) operates as a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purifi …
  • Bukwang Pharmaceutical Co Ltd (003000):企業の財務・戦略的SWOT分析
    Summary Bukwang Pharmaceutical Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexide, chioctaside, levovir, orfil, lonacene, axima, and excel, among others. Its pipeline products comprise JM-0 …
  • InterGen Services, Inc.:電力:M&Aディール及び事業提携情報
    Summary InterGen Services, Inc. (InterGen) is an energy utility that develops, owns, and operates power generation assets which produce energy from coal, gas and renewable sources. It is jointly owned by Ontario Teachers’ Pension Plan and China Huaneng Group/Yudean Guandong Group. The company also o …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • DEPObank – Banca Depositaria Italiana S.p.A:企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana S.p.A - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Rebiotix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that develops treatments for debilitating diseases. The company targets various disease conditions using drugs based on its microbiota restoration therapy platform. It lead product candidate RBX2660 is u …
  • Rooms To Go.com, Inc.:企業の戦略・SWOT・財務情報
    Rooms To Go.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rooms To Go.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Steel Excel Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Steel Excel Inc (Steel Excel) is a provider of technology consulting and business development solutions. The company’s services comprise rogue pressure services, sun well services, black hawk energy services, functional fitness facilities, sports training, strength and conditioning gym facil …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆